medicine & medical supplies

53.7 Debt Service Coverage 673.5 10.1 Total Debt to Equity 0.2 0.3 * calculated by using earnings of current quarter to be estimated for annual earnings ** based on only cost of medicine & medical

and Drug Administration (CFDA), which took around 2 months, that we have got CFDA in early 2018. Sales by product category Consolidated financial statements For the three months period ended March 31

rehabilitation services for patients with diabetes. Kasemrad International Hospital Rattanathibeth opened an Advanced Internal Medicine on the 2nd floor with a team of doctors and personnel who are specialized in

international sales declined dramatically at 46.03% compared to the same period of the previous year. One of the issues was the delayed product delivery after the license was issued from China Food and Drug

granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change

issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures

, e.g., supermarket, food and restaurants (only for takeaway), drug stores.  Online sales continued to grow remarkably by 150.0% YoY.  Gross profit margin from sale of goods improved outstandingly to

cooperated with the Faculty of Medicine Siriraj Hospital  Program to view and collect information of Electrocardiogram and automatic linkage with Hospital Information System (HIS)  Program to send

baht or 6. 56 percent from the previous year, mainly due to a decrease of drug and medical supply cost since the volume of general patients and social security patients decreased. Besides, the Company